Research gives new hope for mental illness treatment
Strong businesses grow strategically through solid research and development. Likewise, R&D provides hope for new innovation in the treatment of mental illnesses.
There are exciting developments in psychiatric research, with three areas showing particular promise: development of novel treatments; insight into the genetic basis of mental disorders; and increased appreciation that the body as well as the brain is involved in mental disorders.
New treatments becoming available
Perhaps the most striking example of an emerging treatment is the development of compounds that target specific receptors in the brain crucial for memory, as well as strengthening or weakening of connections between brain cells over time based on how much they are used.
For instance, a major discovery is that ketamine (a drug used widely as an anesthetic that blocks some of these receptors) effectively treats depression in some individuals that have not responded to standard treatments. Ketamine works rapidly – within hours – while antidepressants can take weeks to work.
Ketamine, however, is not approved by the FDA for the treatment of depression. It can produce psychiatric side effects and has the potential to cause addiction.
This has led to the development of other drugs that also affect these same receptors. Research suggests that some of these drugs may work as quickly and effectively as ketamine to treat depression but without its side effects.
The FDA is now reviewing the safety and efficacy of one of these compounds, esketamine, for people who have failed to respond to standard antidepressant treatment. If esketamine or any of the related drugs successfully make it to market, this could revolutionize depression treatment.
Is mental illness genetic?
New studies on adoption and twins have found that most mental illnesses could be genetic. These includes schizophrenia, bipolar disorder, depression, ADHD, anorexia nervosa, obsessive-compulsive disorder, and we expect that more mental illnesses will be shown to have a genetic link.
People with these disorders who have been adopted into a family show much higher rates of the disorder in their biological family than in their adoptive family members – showing that inherited factors are much more important than shared early environmental factors for the development of the disorder.
Similarly, comparisons of identical and fraternal twins with a certain mental disorder consistently find much higher rates of the disorder in the identical twins (who share 100% of the same genetic material) than fraternal twins (who share 50% of the same genetic material).
Even post-traumatic stress disorder has substantial genetic contributions. In a study of Vietnam veteran twins exposed to combat trauma, the identical twins had higher rates of PTSD in both twins than did the fraternal twins, leading the researchers to conclude that 30% of the cause of PTSD was due to inherited genetic factors.
We have not yet understood the precise genetic mechanisms occurring in mental illness. We know that most mental disorders are complex genetic illnesses (like diabetes) wherein many genes contribute small amounts to creating the illness. That’s why psychiatric genetics research is so important – it can help pave the way for new treatments and even diagnostic tests.
Mental and physical health are connected
There is a myth that mental illnesses are not “real,” but rather character flaws or poor choices. However, growing research indicates that most mental illnesses are brain-based illnesses that also involve physical or bodily abnormalities.
In fact, blood work-studies show many mental illnesses are associated with unhealthy levels of brain and body inflammation similar to what occurs in heart disease and diabetes. For example, people with severe mental illnesses have other medical disorders, including heart disease, stroke, diabetes, obesity, chronic pain, and increased mortality. People with schizophrenia and bipolar disorder live 20 years fewer than average due to increased rates of cardiovascular death.
More funding is needed
Exciting psychiatric research should improve the lives of those living with psychiatric disorders. Unfortunately, mental health research is massively underfunded as compared to research for other diseases. Given that 1 in 5 people will experience a psychiatric disorder during their lifetime, it is crucial that this important research is adequately funded.
Source: American City Business Journals.